These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 825516)

  • 21. A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children.
    Breiman RF; Brooks WA; Goswami D; Lagos R; Borja-Tabora C; Lanata CF; Londoño JA; Lum LC; Rappaport R; Razmpour A; Walker RE; Gruber WC; Forrest BD
    Vaccine; 2009 Sep; 27(40):5472-9. PubMed ID: 19616493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent oral poliovirus and rhesus-human reassortant rotavirus vaccination: effects on immune responses to both vaccines and on efficacy of rotavirus vaccines. The US Rotavirus Vaccine Efficacy Group.
    Rennels MB; Ward RL; Mack ME; Zito ET
    J Infect Dis; 1996 Feb; 173(2):306-13. PubMed ID: 8568290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. THE PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. I. DERIVATION OF NEW TYPE 3 ATTENUATED POLIOVIRUSES AND THEIR LABORATORY CHARACTERISTICS.
    VONKA V; JANDA Z; SIMON J
    Arch Gesamte Virusforsch; 1964 Jun; 14():599-610. PubMed ID: 14247356
    [No Abstract]   [Full Text] [Related]  

  • 24. [Genetic changes in strains of poliovirus type 2 isolated from patients with vaccine-associated paralytic poliomyelitis].
    Sosa-Díaz RY; Más-Lago P; Valdés-Ramírez O; Sarmiento-Pérez L
    Rev Neurol; 2003 May 1-15; 36(9):812-6. PubMed ID: 12717666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys.
    Marchevsky RS; Freire MS; Coutinho ES; Galler R
    Virology; 2003 Nov; 316(1):55-63. PubMed ID: 14599790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Surveillance of adverse effects following immunization (AEFI)].
    Magdzik W
    Przegl Epidemiol; 1992; 46(1-2):27-33. PubMed ID: 1335588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines.
    Steele AD; De Vos B; Tumbo J; Reynders J; Scholtz F; Bos P; de Beer MC; Van der Merwe CF; Delem A
    Vaccine; 2010 Sep; 28(39):6542-8. PubMed ID: 18786585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccines and vaccine policy: the poliomyelitis example.
    Melnick JL
    Hosp Pract; 1978 Jan; 13(1):41-2, 47. PubMed ID: 621082
    [No Abstract]   [Full Text] [Related]  

  • 29. Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine--supplementary statement.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1987 Dec; 36(48):795-8. PubMed ID: 3119980
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prevention - is it useful?].
    Valsecchi M
    Ig Sanita Pubbl; 2016; 72(1):69-76. PubMed ID: 27266054
    [No Abstract]   [Full Text] [Related]  

  • 31. Infectious disease. Vaccine-related polio outbreak in Nigeria raises concerns.
    Roberts L
    Science; 2007 Sep; 317(5846):1842. PubMed ID: 17901301
    [No Abstract]   [Full Text] [Related]  

  • 32. Leads from the MMWR. Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine--supplementary statement.
    JAMA; 1988 Jan; 259(3):345-6. PubMed ID: 3336150
    [No Abstract]   [Full Text] [Related]  

  • 33. Vaccine-associated paralytic poliomyelitis.
    Mermel L; Sanchez de Mora D; Sutter RW; Pallansch MA
    N Engl J Med; 1993 Sep; 329(11):810-1. PubMed ID: 8350905
    [No Abstract]   [Full Text] [Related]  

  • 34. Vaccination with inactivated poliovirus vaccine and oral poliovirus vaccine in Denmark.
    von Magnus H; Petersen I
    Rev Infect Dis; 1984; 6 Suppl 2():S471-4. PubMed ID: 6740095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys.
    Gerhardt GA; Cass WA; Huettl P; Brock S; Zhang Z; Gash DM
    Brain Res; 1999 Jan; 817(1-2):163-71. PubMed ID: 9889359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laboratory tests for live attenuated poliovirus vaccines.
    Wood DJ; Macadam AJ
    Biologicals; 1997 Mar; 25(1):3-15. PubMed ID: 9167004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infectious diseases. Polio outbreak raises questions about vaccine.
    Greensfelder L
    Science; 2000 Dec; 290(5498):1867-9. PubMed ID: 11187033
    [No Abstract]   [Full Text] [Related]  

  • 38. Neuromelanin in manganese-exposed primates.
    Gupta SK; Murthy RC; Chandra SV
    Toxicol Lett; 1980 Jun; 6(1):17-20. PubMed ID: 6775393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Environmental Isolation of Circulating Vaccine-Derived Poliovirus After Interruption of Wild Poliovirus Transmission - Nigeria, 2016.
    Etsano A; Damisa E; Shuaib F; Nganda GW; Enemaku O; Usman S; Adeniji A; Jorba J; Iber J; Ohuabunwo C; Nnadi C; Wiesen E
    MMWR Morb Mortal Wkly Rep; 2016 Aug; 65(30):770-3. PubMed ID: 27490081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Recent advance in research on the incidence of paralysis following immunization with live oral polio vaccine].
    Hu XM
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Apr; 6(2):125-7. PubMed ID: 2990717
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.